JP2016535782A5 - - Google Patents

Download PDF

Info

Publication number
JP2016535782A5
JP2016535782A5 JP2016552448A JP2016552448A JP2016535782A5 JP 2016535782 A5 JP2016535782 A5 JP 2016535782A5 JP 2016552448 A JP2016552448 A JP 2016552448A JP 2016552448 A JP2016552448 A JP 2016552448A JP 2016535782 A5 JP2016535782 A5 JP 2016535782A5
Authority
JP
Japan
Prior art keywords
item
solution
spray
subject
spray solution
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2016552448A
Other languages
English (en)
Japanese (ja)
Other versions
JP2016535782A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2014/063784 external-priority patent/WO2015066664A2/en
Publication of JP2016535782A publication Critical patent/JP2016535782A/ja
Publication of JP2016535782A5 publication Critical patent/JP2016535782A5/ja
Pending legal-status Critical Current

Links

JP2016552448A 2013-11-04 2014-11-04 被験者の気道への酵素の投与のための組成物及び方法 Pending JP2016535782A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201361899739P 2013-11-04 2013-11-04
US61/899,739 2013-11-04
PCT/US2014/063784 WO2015066664A2 (en) 2013-11-04 2014-11-04 Compositions and methods for administration of an enzyme to a subject's airway

Publications (2)

Publication Number Publication Date
JP2016535782A JP2016535782A (ja) 2016-11-17
JP2016535782A5 true JP2016535782A5 (enExample) 2017-12-14

Family

ID=53005414

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2016552448A Pending JP2016535782A (ja) 2013-11-04 2014-11-04 被験者の気道への酵素の投与のための組成物及び方法

Country Status (11)

Country Link
US (2) US20160279209A1 (enExample)
EP (1) EP3065705A4 (enExample)
JP (1) JP2016535782A (enExample)
KR (1) KR20160078986A (enExample)
CN (1) CN105764488A (enExample)
AU (1) AU2014341862A1 (enExample)
CA (1) CA2928759A1 (enExample)
CL (1) CL2016001062A1 (enExample)
MX (1) MX2016005720A (enExample)
PE (1) PE20160789A1 (enExample)
WO (1) WO2015066664A2 (enExample)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2875853T3 (es) 2013-03-15 2021-11-11 Univ Texas Método de tratar fibrosis
WO2020055812A1 (en) 2018-09-10 2020-03-19 Lung Therapeutics, Inc. Modified peptide fragments of cav-1 protein and the use thereof in the treatment of fibrosis
WO2021180068A1 (zh) * 2020-03-09 2021-09-16 泰伦基国际有限公司 一种治疗2019新型冠状病毒引发疾病的方法和药物

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4790305A (en) * 1986-06-23 1988-12-13 The Johns Hopkins University Medication delivery system
EP0266032A1 (en) 1986-08-29 1988-05-04 Beecham Group Plc Modified fibrinolytic enzyme
US5302390A (en) 1987-07-01 1994-04-12 Beecham Group Plc Hybrid proteins of human plasminogen and human t-PA, pharmaceutical compositions and methods of treatment
US5531219A (en) * 1994-11-04 1996-07-02 Alliance Pharmaceutical Corp. Use of liquid fluorocarbons to facilitate pulmonary drug delivery
AU3765897A (en) * 1996-08-14 1998-03-06 Jurgen Brodersen Gram Use of a plasminogen activator for the treatment of pulmonary disorders
US20030113271A1 (en) * 1997-01-29 2003-06-19 University Technology Corporation Formulations for pulmonary delivery
KR20040090962A (ko) * 2001-12-21 2004-10-27 엔바이로스크럽 테크놀러지스 코퍼레이션 망간 산화물의 전처리 및 재생
CA2512672A1 (en) * 2003-01-09 2004-07-29 Arizeke Pharmaceuticals Inc. Methods of treating lung diseases
US20050169908A1 (en) 2004-01-23 2005-08-04 Kazunori Murakami Use of aerosolized antithrombin to treat acute lung injury
US20060198940A1 (en) 2005-03-04 2006-09-07 Mcmorrow David Method of producing particles utilizing a vibrating mesh nebulizer for coating a medical appliance, a system for producing particles, and a medical appliance
US20070157931A1 (en) 2005-07-11 2007-07-12 Richard Parker System and method for optimized delivery of an aerosol to the respiratory tract
DK1962869T3 (da) * 2005-12-21 2013-06-24 Solaeromed Inc Behandling af luftvejssygdomme
SI22865A (sl) 2008-09-25 2010-03-31 Univerza@V@Ljubljani Peptid uroaktivin kot aktivator encima urokinaze
WO2010062995A2 (en) * 2008-11-26 2010-06-03 Five Prime Therapeutics, Inc. Compositions and methods for regulating collagen and smooth muscle actin expression by serpine2
DE102009031274A1 (de) * 2009-06-30 2011-01-13 Justus-Liebig-Universität Giessen Liposomen zur pulmonalen Applikation
JP2014529614A (ja) 2011-08-29 2014-11-13 トリフォイリウム・エピエス 放射線により誘発されるまたは化学療法により誘発される肺機能不全の治療または予防のための組成物および方法

Similar Documents

Publication Publication Date Title
Lavorini et al. New inhaler devices-the good, the bad and the ugly
Ari et al. Aerosol delivery device selection for spontaneously breathing patients: 2012
JP2011144201A5 (enExample)
WO2005084638A3 (en) Formulations decreasing infectivity of pulmonary diseases
Janssens et al. Aerosol therapy: the special needs of young children
EA201791780A1 (ru) Ингаляционный раствор тиотропия для небулайзерного распыления
TR201900557T4 (tr) Atomizasyon ile bir pulmoner surfaktanın uygulanmasına yönelik sistem.
JP2007507423A (ja) 病原体感染の危険を低減する方法
Smaldone Advances in aerosols: adult respiratory disease
HRP20231621T1 (hr) Formulacije ciklosporina za upotrebu u prevenciji ili liječenju plućnog kroničnog odbacivanja transplantanta
CN203829435U (zh) 呼吸内科给药装置
CN201175510Y (zh) 一种医疗喷雾器
CN107551364A (zh) 儿童雾化器
MX2020010977A (es) Procedimientos de tratamiento de infecciones fúngicas.
Parks Mist therapy: rationale and practice
CA2931172C (en) Treatment for airway cast obstruction
Pongracic Asthma delivery devices: age-appropriate use
CN204233551U (zh) 辅助呼吸气雾气体的装置
CN204428565U (zh) 儿童喷雾器
CN205287144U (zh) 一种医用雾化器
CN208049145U (zh) 一种防过敏的雾化吸入器
CN204932497U (zh) 药物雾化器
CN205127033U (zh) 一种便携式盐疗呼吸瓶
CN211188613U (zh) 一种呼吸科用药雾化器
Mazela Aerosolization and nebulization